HFCAS OpenIR

浏览/检索结果: 共90条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial 期刊论文
BRITISH JOURNAL OF CANCER, 2022
作者:  Qin, Shukui;  Li, Jin;  Zhong, Haijun;  Jin, Chuan;  Chen, Lili;  Yuan, Xianglin;  Fan, Qingxia;  Chen, Kehe;  Cao, Peiguo;  Xiao, Jianjun;  Jiang, Da;  Zhang, Tao;  Zhang, Hongyu;  Wang, Xicheng;  Wang, Wei;  Han, Lin;  Wang, Qingyu;  Zhu, Jun
收藏  |  浏览/下载:49/0  |  提交时间:2022/12/22
Review on recent progress in on-line monitoring technology for atmospheric pollution source emissions in China 期刊论文
Journal of Environmental Sciences, 2022
作者:  Wang HQ(王焕钦)
浏览  |  Adobe PDF(1568Kb)  |  收藏  |  浏览/下载:81/46  |  提交时间:2022/12/26
Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial 期刊论文
BMC MEDICINE, 2022, 卷号: 20
作者:  Song, Zhengbo;  Lou, Guangyuan;  Wang, Yina;  Yang, Zhiping;  Wang, Wenxian;  Ji, Yongling;  Chen, Shiqing;  Xu, Chunwei;  Hu, Xiao;  Zhang, Yiping
收藏  |  浏览/下载:25/0  |  提交时间:2022/12/23
Thymic epithelial tumors  Apatinib  Efficacy  Toxicities  
Efficacy and safety of radiotherapy combined with raltitrexed and irinotecan for treating unresectable recurrent colorectal cancer: a single-arm phase II trial 期刊论文
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022
作者:  Li, Xinghui;  Shen, Jinwen;  Xia, Fan;  Zhu, Ji
收藏  |  浏览/下载:35/0  |  提交时间:2022/12/23
Colorectal cancer  local recurrence  intensity-modulated radiotherapy  irinotecan  raltitrexed  
High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma 期刊论文
BMC CANCER, 2022, 卷号: 22
作者:  Chen, Xi;  Kong, Haiying;  Luo, Linxiang;  Han, Shuiyun;  Lei, Tao;  Yu, Haifeng;  Guo, Na;  Li, Cong;  Peng, Shuailing;  Dong, Xiaowu;  Yang, Haiyan;  Wu, Meijuan
收藏  |  浏览/下载:64/0  |  提交时间:2022/02/14
Hodgkin lymphoma  PD-1 inhibitor  PD-L1 inhibitor  PD-L2  Molecular phenotype  Tumor microenvironment  
Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin vs Capecitabine for Stage II to III Rectal Cancer A Randomized Clinical Trial 期刊论文
JAMA NETWORK OPEN, 2021, 卷号: 4
作者:  Li, Ning;  Zhu, Yuan;  Liu, Lu-Ying;  Feng, Yan-Ru;  Wang, Wen-Ling;  Wang, Jun;  Wang, Hao;  Li, Gao-Feng;  Tang, Yuan;  Hu, Chen;  Liu, Wen-Yang;  Ren, Hua;  Wang, Shu-Lian;  Wang, Wei-Hu;  Song, Yong-Wen;  Liu, Yue-Ping;  Fang, Hui;  Tang, Yu;  Lu, Ning-Ning;  Chen, Bo;  Qi, Shu-Nan;  Liu, Xin-Fan;  Li, Ye-Xiong;  Jin, Jing
收藏  |  浏览/下载:61/0  |  提交时间:2022/01/10
Tislelizumab Plus GemOx in Patients with Relapsed/Refractory Classic Hodgkin Lymphoma: A Single-Arm, Multi-Center Phase II Trial 期刊论文
BLOOD, 2021, 卷号: 138
作者:  Ding, Kaiyang;  Liu, Hailing;  Yang, Haiyan;  Cao, Lei;  Zhao, Xiaoli;  Wu, Wei;  Zhang, Xiaoyan;  Wang, Li;  Xu, Wei;  Zhu, Huayuan;  Li, Jianyong;  Fan, Lei
收藏  |  浏览/下载:31/0  |  提交时间:2022/12/23
Liposome-paclitaxel and carboplatin combination chemoradiotherapy for patients with locally advanced esophageal squamous cell carcinoma 期刊论文
CANCER RADIOTHERAPIE, 2021, 卷号: 25
作者:  Zeng, J.;  Cui, X.;  Cheng, L.;  Chen, Y.;  Du, X.;  Sheng, L.
收藏  |  浏览/下载:62/0  |  提交时间:2021/08/31
Esophageal squamous cell carcinoma  Liposome-paclitaxel  Chemoradiotherapy  Toxicities  
Pyrotinib as neoadjuvant therapy for HER2+breast cancer: A multicenter, randomized, controlled, phase II trial. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Ding, Xiaowen;  Mo, Wenju;  Xie, Xiaohong;  Wang, Ouchen;  Ding, Yuqin;  Zhao, Shuai;  He, Xiangming;  Feng, Weiliang;  Zou, Dehong;  Yang, Hongjian
收藏  |  浏览/下载:51/0  |  提交时间:2022/01/10
Atezolizumab in combination with bevacizumab in patients with unresectable locally advanced or metastatic mucosal melanoma: Interim analysis of an open-label phase II trial. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Si, Lu;  Fang, Meiyu;  Chen, Yu;  Mao, Lili;  Zhang, Peng;  Lin, Jing;  Bai, Xue;  Cao, Xiao;  Chen, Yi;  Guo, Jun
收藏  |  浏览/下载:44/0  |  提交时间:2022/01/10